ÂÜÀòÂÒÂ×

Laurent Fischer currently serves as Chair at Teal Omics and has held the position of President and Chief Executive Officer at Adverum Biotechnologies, Inc. since June 2020. In addition, Laurent Fischer has been an Independent Director at Lycia Therapeutics and a member of the Board of Directors at Mirum Pharmaceuticals since December 2019 and June 2019, respectively. From September 2017 to June 2023, Laurent Fischer was Chairman of the Board at CTI BioPharma. Previous roles include Board Member at Senti Biosciences, Senior Vice President and Liver Therapeutic Area Head at Allergan, Chief Executive Officer at Tobira Therapeutics, and Interim CEO at Jennerex Biotherapeutics, among others. Laurent Fischer earned an M.D. in Medicine from the University of Geneva between 1982 and 1989.